Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market Report 2026

Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market Overview

• Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device market size has reached to $1.33 billion in 2025 • Expected to grow to $2.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.3% • Growth Driver: Rising Healthcare Expenditure Fueling the Growth Of The Market Due To Increasing Investment In Advanced Treatment Technologies • Market Trend: Integration Of Bioengineered 3D Anatomical Design To Improve Treatment Precision And Personalization • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market?

An artificial intelligence (AI)-enhanced sleep apnea oral device is a smart, custom-fitted appliance designed to keep the airway open during sleep by gently repositioning the jaw or tongue. It uses artificial intelligence to monitor breathing patterns in real time, learning from the user’s sleep data to automatically adjust for better effectiveness and comfort. The main product types of artificial intelligence (AI)-enhanced sleep apnea oral devices are mandibular advancement devices, tongue-retaining devices, hybrid devices, and others. A mandibular advancement device functions by gently positioning the lower jaw forward during sleep to expand the upper airway and prevent airway collapse. These devices incorporate advanced technologies such as artificial intelligence (AI)-based monitoring, smart sensors, data analytics, and others and are distributed through online and offline channels. They are used for applications including obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome, serving end users including hospitals, sleep clinics, homecare settings, and others.

What Is The Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market Growth Forecast?

The artificial intelligence (ai)-enhanced sleep apnea oral device market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to AI-enabled adaptive sleep therapy, growth in home-based sleep treatment, integration with sleep monitoring apps, demand for non-invasive solutions, personalized sleep analytics. Major trends in the forecast period include personalized oral appliance therapy, real-time sleep pattern optimization, ai-based comfort adjustment, home sleep disorder management, data-driven therapy compliance.

Global Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market Segmentation

1) By Product Type: Mandibular Advancement Devices, Tongue Retaining Devices, Hybrid Devices 2) By Technology: Artificial Intelligence (AI)-Based Monitoring, Smart Sensors, Data Analytics, Other Technologies 3) By Distribution Channel: Online, Offline 4) By End User: Hospitals, Sleep Clinics, Homecare Settings, Other End-Users Subsegments: 1) By Mandibular Advancement Devices: Mandibular Repositioning Devices, Adjustable Mandibular Devices, Custom-Fit Mandibular Devices 2) By Tongue Retaining Devices: Standard Tongue Retaining Devices, Custom Tongue Retaining Devices, Vacuum-Based Tongue Retaining Devices 3) By Hybrid Devices: Dual-Mechanism Hybrid Devices, Combined Mandibular-Tongue Hybrid Devices

What Is The Driver Of The Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market?

The rising healthcare expenditure is expected to propel the growth of the artificial intelligence (AI)-enhanced sleep apnea oral device market going forward. Healthcare expenditure is the total spending on medical services, treatments, and health-related goods to maintain or improve population health. Healthcare expenditure is rising due to the increasing prevalence of chronic diseases, which require long-term treatments and continuous medical care, thereby significantly driving up overall healthcare costs. Healthcare expenditure supports the adoption of artificial intelligence (AI)-enhanced sleep apnea oral devices by enabling greater investment in advanced diagnostic and treatment technologies that improve patient outcomes and reduce long-term healthcare costs. For instance, in April 2025, according to the Office for National Statistics, a UK-based government agency, government-funded healthcare accounts for the majority of total health spending in the UK, reaching $346 billion (£258 billion) in 2024, which represents a 2.5% real-terms rise compared to 2023. Therefore, the rising healthcare expenditure is driving the growth of the artificial intelligence (AI)-enhanced sleep apnea oral device industry.

Key Players In The Global Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market

Major companies operating in the artificial intelligence (ai)-enhanced sleep apnea oral device market are SomnoMed Limited, ProSomnus Sleep Technologies, Panthera Dental, Glidewell Laboratories Inc., DynaFlex Inc., Vivos Therapeutics Inc., OpenAirway Dental Solutions Ltd., Airway Management Inc., Apnea Sciences Corporation, OravanOSA, Myerson LLC, Braebon Medical Corporation, Klearway Inc., TOMED GmbH, Apex Dental Sleep Lab Inc., Dream Systems LLC, OrthoApnea S.L., Dentulu Inc., Airway Labs, Zyppah Inc.

Global Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market Trends and Insights

Major companies operating in the artificial intelligence (AI)-enhanced sleep apnea oral device market are focusing on developing advanced designs, such as bioengineered 3D anatomical design to enhance device precision, personalization, and treatment efficacy. Bioengineered 3D anatomical design is an advanced technology that uses AI and robotic manufacturing to create personalized oral devices that fit each patient’s dental and airway structure, improving comfort, jaw alignment, and breathing efficiency. For instance, in June 2025, ProSomnus Inc., a US-based medical device company, launched EVO Guided, a new precision, custom oral device designed for the treatment of obstructive sleep apnea (OSA). It offers superior comfort with a lingual-less design, improving patient compliance and reducing side effects compared to traditional appliances. Its advanced anatomical fit and patented post mechanism help dilate airway regions effectively, making it a highly effective, FDA-cleared alternative to CPAP therapy.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market?

In September 2024, US ENT Partners, a US-based group purchasing organization, collaborated with ProSomnus Inc. to enhance access to precision oral appliance therapy for patients suffering from obstructive sleep apnea (OSA). This partnership aims to empower ENT and dental sleep medicine professionals with advanced, AI-enhanced oral appliance therapy solutions designed to improve patient outcomes, simplify access to effective OSA treatment, and promote practice growth through clinical and reimbursement support. ProSomnus Inc. is a US-based medical device company that provides an artificial intelligence (AI)-enhanced sleep apnea oral device.

Regional Outlook

North America was the largest region in the artificial intelligence (AI)-enhanced sleep apnea oral device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market?

The artificial intelligence (AI)-enhanced sleep apnea oral device market consists of revenues earned by entities by providing services such as custom fitting, remote monitoring, sleep data analysis, teleconsultation, maintenance and repair, and software updates. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced sleep apnea oral device market also includes sales of oral appliances, sensor modules, adaptive control systems, and digital sleep trackers. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.